GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bakhu Holdings Corp (OTCPK:BKUH) » Definitions » Net Current Asset Value

Bakhu Holdings (Bakhu Holdings) Net Current Asset Value : $-0.03 (As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bakhu Holdings Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Bakhu Holdings's net current asset value per share for the quarter that ended in Jan. 2024 was $-0.03.

The historical rank and industry rank for Bakhu Holdings's Net Current Asset Value or its related term are showing as below:

BKUH's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.51
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Bakhu Holdings Net Current Asset Value Historical Data

The historical data trend for Bakhu Holdings's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bakhu Holdings Net Current Asset Value Chart

Bakhu Holdings Annual Data
Trend Jul08 Jul09 Jul10 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.01 -0.03 -0.03

Bakhu Holdings Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.03 -0.03 -0.03 -0.03

Competitive Comparison of Bakhu Holdings's Net Current Asset Value

For the Drug Manufacturers - Specialty & Generic subindustry, Bakhu Holdings's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bakhu Holdings's Price-to-Net-Current-Asset-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bakhu Holdings's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Bakhu Holdings's Price-to-Net-Current-Asset-Value falls into.



Bakhu Holdings Net Current Asset Value Calculation

Bakhu Holdings's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Jul. 2023 is calculated as

Net Current Asset Value Per Share(A: Jul. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.003-9.797-0-0)/301.303
=-0.03

Bakhu Holdings's Net Current Asset Value (NCAV) per share for the quarter that ended in Jan. 2024 is calculated as

Net Current Asset Value Per Share(Q: Jan. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.426-10.607-0-0)/301.303
=-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bakhu Holdings  (OTCPK:BKUH) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Bakhu Holdings Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Bakhu Holdings's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Bakhu Holdings (Bakhu Holdings) Business Description

Traded in Other Exchanges
N/A
Address
One World Trade Center, Suite 130, Long Beach, CA, USA, 90831
Bakhu Holdings Corp is a development stage company engaged in the production, manufacturing, and sale of cannabis and byproducts. The company also provides cannabis-related research, teaching and education for both medical and other purposes, and all medical uses and applications of cannabis, within the Territory.
Executives
Tom Vaknin director SPYROU KYPRIANOU 16, PYGROS / LIMMASOL G4 4529
Moshe Morgenstern director MENACHEM BEGIN 88, PETAH TIKVAH/CENTRAL DISTRICT L3 49504
Geoffrey Robert Dixon 10 percent owner 16 SHOBY LANE, GRIMSTON X0 LE14 3DD
Michael Richard Hawthorne officer: Deputy CEO 20 LARKSBOROUGH AVENUE, COUNTY DOWN X0 BT23 8SU
Garcia La Sienra Garcia Juan Carlos director, officer: CFO 3 SHANEWOOD CT, THE WOODLANDS TX 77382
Sagi Rami Rozen director HOUSE NUMBER 8, 8 AGIAS TRIADAS STREET (MOUTTAGIAKA), LIMASSOL G4 4527
Cell Science Holding, Ltd. 10 percent owner PANTELI KATELARI 18A, AGIOS IOANNIS, LIMASSOL G4 3012
Mentone, Ltd. 10 percent owner 3 COPLOW CRESCENT, SYSTON, LEICESTER X0 LE7 2JE
Inter-m Traders Fz, Lle 10 percent owner 18A PENTELI KATELARI, LIMASSOL G4 3021
Thomas K Emmitt director, officer: President, CEO and Secretary ONE WORLD TRADE CENTER, SUITE 130, LONG BEACH CA 90831
Aristotle Popolizio director 206 PASSAIC AVENUE, ROSELAND NJ 07068
Evripides Drakos director 139C GLOUCESTER TERRACE, LANCASTER GATE, LONDON X0 W2 6DX
Peter Whitton director 3 COPLOW CRESCENT, SYSTON LEICESTER X0 LE7 2JE
Oz Corp 10 percent owner 24328 VERMONT AVENUE, SUITE 300, HARBOR CITY CA 90710